Goal and Learning Outcomes

The goal of this continuing education program is to provide registered dietitians, health educators, nurses, and physical therapists with guidelines on how athletes and active individuals should fuel before, during, and after exercise. After studying the information presented here, you will be able to:
  • Identify appropriate daily carbohydrate intake guidelines for a variety of athletes.
  • Describe the rationale for ingestion of carbohydrates before, during, and after exercise based on a variety of factors, including body weight, exercise duration, and intensity of activity being performed.
  • Describe the effectiveness of intake of various forms and sources of carbohydrate and how intake of other substrates influences the body’s use of carbohydrate.
  • Identify current recommendations for protein intake during and after exercise to enhance carbohydrate usage and performance.

Course Authors

Accreditation Information


In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791



Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses


Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.



None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.